Page last updated: 2024-08-24

1,2-distearoyllecithin and sdz psc 833

1,2-distearoyllecithin has been researched along with sdz psc 833 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Krishna, R; Mayer, LD	1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and sdz psc 833

Article	Year
Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors. Cancer research, 1997, Dec-01, Volume: 57, Issue:23 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cholesterol; Cyclosporins; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Female; Leukemia P388; Liposomes; Metabolic Clearance Rate; Mice; Phosphatidylcholines; Tissue Distribution	1997

Article

Year

Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.

Cancer research, 1997, Dec-01, Volume: 57, Issue:23

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cholesterol; Cyclosporins; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Female; Leukemia P388; Liposomes; Metabolic Clearance Rate; Mice; Phosphatidylcholines; Tissue Distribution

1997